(Q35595950)

English

An evaluation of the emerging interventions against Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in children

scientific article published on 13 April 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 August 2017

5 references

23 March 2019

20 June 2019

4 August 2019

1 July 2020

7 December 2020

An evaluation of the emerging interventions against Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in children (English)

1 reference

Europe PubMed Central

9 August 2017

respiratory syncytial virus infectious disease

4 references

23 March 2019

20 June 2019

4 August 2019

1 July 2020

1 reference

4 August 2019

respiratory tract infection

1 reference

7 December 2020

8

object named as

Igor Rudan

0 references

4

object named as

Lina Zgaga

0 references

Evropi Theodoratou

object named as

Evropi Theodoratou

3

0 references

1

object named as

Harish Nair

1 reference

Europe PubMed Central

9 August 2017

Eric A F Simões

6

object named as

Eric A F Simões

1 reference

Europe PubMed Central

9 August 2017

9

object named as

Harry Campbell

1 reference

Europe PubMed Central

9 August 2017

5

object named as

Tanvir Huda

1 reference

Europe PubMed Central

9 August 2017

author name string

Vasundhara R Verma

2

1 reference

Europe PubMed Central

9 August 2017

Peter F Wright

7

1 reference

Europe PubMed Central

9 August 2017

language of work or name

0 references

publication date

13 April 2011

6 references

Europe PubMed Central

9 August 2017

23 March 2019

20 June 2019

4 August 2019

1 July 2020

7 December 2020

BMC Public Health

6 references

Europe PubMed Central

9 August 2017

23 March 2019

20 June 2019

4 August 2019

1 July 2020

7 December 2020

11 Suppl 3

1 reference

Europe PubMed Central

9 August 2017

S30

1 reference

Europe PubMed Central

9 August 2017

copyright license

Creative Commons Attribution 2.0 Generic

5 references

Europe PubMed Central

23 March 2019

Europe PubMed Central

20 June 2019

Europe PubMed Central

4 August 2019

Europe PubMed Central

1 July 2020

Europe PubMed Central

7 December 2020

copyright status

0 references

on focus list of Wikimedia project

0 references

https://scigraph.springernature.com/pub.10.1186/1471-2458-11-s3-s30

0 references

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Setting priorities for global mental health research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Challenges in developing a pediatric RSV vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Setting research priorities to reduce global mortality from childhood diarrhoea by 2015.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Setting priorities in global child health research investments: guidelines for implementation of CHNRI method

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Setting priorities in global child health research investments: universal challenges and conceptual framework

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Climatic, temporal, and geographic characteristics of respiratory syncytial virus disease in a tropical island population.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Setting priorities in global child health research investments: addressing values of stakeholders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Setting priorities in child health research investments for South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Human and bovine respiratory syncytial virus vaccine research and development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Prospects for prevention of childhood infections by maternal immunization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

New generation live vaccines against human respiratory syncytial virus designed by reverse genetics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Recombinant Sendai virus as a novel vaccine candidate for respiratory syncytial virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Achieving universal coverage with health interventions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Recombinant Sendai virus expressing the G glycoprotein of respiratory syncytial virus (RSV) elicits immune protection against RSV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Differential pricing for pharmaceuticals: reconciling access, R&D and patents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Maternal immunisation in developing countries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Maternal immunization and malaria in pregnancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Cost of hospitalization for respiratory syncytial virus chest infection and implications for passive immunization strategies in a developing nation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Clinical experience with respiratory syncytial virus vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Economic analyses of respiratory syncytial virus immunoprophylaxis in high-risk infants: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Immunoprophylaxis of respiratory syncytial virus: global experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Influence of maternal antibodies on neonatal immunization against respiratory viruses.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Respiratory syncytial virus infection in tropical and developing countries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Risk of primary infection and reinfection with respiratory syncytial virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Evaluation in chimpanzees of vaccinia virus recombinants that express the surface glycoproteins of human respiratory syncytial virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

Immunogenicity of recombinant adenovirus-respiratory syncytial virus vaccines with adenovirus types 4, 5, and 7 vectors in dogs and a chimpanzee

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

12 July 2018

The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S30

21 January 2018

Sequelae of severe respiratory syncytial virus infection in infancy and early childhood among Alaska Native children

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S30

21 January 2018

Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S30

21 January 2018

Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S30

21 January 2018

Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S30

21 January 2018

The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S30

21 January 2018

Current respiratory syncytial virus prevention strategies in high-risk infants.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S30

21 January 2018

Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S30

21 January 2018

Prevalence of respiratory syncytial virus IgG antibodies in infants living in a rural area of Mozambique

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S30

21 January 2018

Respiratory syncytial virus vaccine: a systematic overview with emphasis on respiratory syncytial virus subunit vaccines

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S30

21 January 2018

Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S30

21 January 2018

Respiratory syncytial virus: back to basics

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S30

21 January 2018

Phase-I study MEDI-534, of a live, attenuated intranasal vaccine against respiratory syncytial virus and parainfluenza-3 virus in seropositive children

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S30

21 January 2018

Development of a PIV-vectored RSV vaccine: preclinical evaluation of safety, toxicity, and enhanced disease and initial clinical testing in healthy adults.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S30

21 January 2018

Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S30

21 January 2018

A prime-boost vaccination strategy using attenuated Salmonella typhimurium and a replication-deficient recombinant adenovirus vector elicits protective immunity against human respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S30

21 January 2018

Respiratory syncytial virus prophylaxis: cost-effective analysis in Argentina

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S30

21 January 2018

Mind the gap: equity and trends in coverage of maternal, newborn, and child health services in 54 Countdown countries.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S30

21 January 2018

Making health systems more equitable.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S30

21 January 2018

Setting priorities in global child health research investments: assessment of principles and practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

26 September 2018

The economic burden of respiratory syncytial virus-associated bronchiolitis hospitalizations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

26 September 2018

Co-coverage of preventive interventions and implications for child-survival strategies: evidence from national surveys

2 references

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S30

21 January 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

15 November 2018

Childhood pneumonia and diarrhoea: setting our priorities right

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S30

21 January 2018

Research priorities for health of people with disabilities: an expert opinion exercise

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S30

21 January 2018

Research Priorities to Reduce Global Mortality From Newborn Infections by 2015

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231904

15 November 2018

High rate of indigenous bronchiolitis and palivuzumab

1 reference

https://pubmed.ncbi.nlm.nih.gov/21501449

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21501449

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21501449

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of influenza vaccination of healthy children

1 reference

https://pubmed.ncbi.nlm.nih.gov/21501449

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The complex challenge of setting priorities in health research investments

1 reference

https://pubmed.ncbi.nlm.nih.gov/21501449

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Respiratory syncytial virus vaccine development

1 reference

https://pubmed.ncbi.nlm.nih.gov/21501449

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Respiratory syncytial virus market

1 reference

https://pubmed.ncbi.nlm.nih.gov/21501449

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2458-11-S3-S30

1 reference

Europe PubMed Central

9 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35595950&oldid=1747726946"